AU6751000A - Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery - Google Patents

Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery

Info

Publication number
AU6751000A
AU6751000A AU67510/00A AU6751000A AU6751000A AU 6751000 A AU6751000 A AU 6751000A AU 67510/00 A AU67510/00 A AU 67510/00A AU 6751000 A AU6751000 A AU 6751000A AU 6751000 A AU6751000 A AU 6751000A
Authority
AU
Australia
Prior art keywords
transmucosal
histamine
enhancing compound
drug delivery
transdermal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67510/00A
Inventor
Judy Senior
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxim Pharmaceuticals Inc
Original Assignee
Maxim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharmaceuticals Inc filed Critical Maxim Pharmaceuticals Inc
Publication of AU6751000A publication Critical patent/AU6751000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67510/00A 1999-07-30 2000-07-28 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery Abandoned AU6751000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14664199P 1999-07-30 1999-07-30
US60146641 1999-07-30
PCT/US2000/020757 WO2001008706A1 (en) 1999-07-30 2000-07-28 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery

Publications (1)

Publication Number Publication Date
AU6751000A true AU6751000A (en) 2001-02-19

Family

ID=22518302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67510/00A Abandoned AU6751000A (en) 1999-07-30 2000-07-28 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery

Country Status (5)

Country Link
EP (1) EP1229939A1 (en)
AU (1) AU6751000A (en)
CA (1) CA2393452A1 (en)
HK (1) HK1048770A1 (en)
WO (1) WO2001008706A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368727B (en) * 2013-12-17 2019-10-14 Univ Fraser Simon Compounds, compositions and methods for attracting and/or arresting bed bugs.
EP3213769A4 (en) * 2014-10-30 2018-02-21 Asahi Kasei Kabushiki Kaisha Transdermal-absorption-promoter and transdermal-absorption-promoting supplement
CN110075063A (en) * 2019-05-27 2019-08-02 合肥亿帆生物医药有限公司 A kind of Maxamine injection and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521405A (en) * 1982-05-17 1985-06-04 John McMichael Methods and materials for treatment of disease states involving immunological factors
HU223205B1 (en) * 1996-12-03 2004-03-29 Zoltán Dárdai Topical pharmaceutical composition for applicating peptidelike compounds into the living organismus
US6270781B1 (en) * 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Also Published As

Publication number Publication date
CA2393452A1 (en) 2001-02-08
WO2001008706A1 (en) 2001-02-08
HK1048770A1 (en) 2003-04-17
EP1229939A1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
AU7691300A (en) A dual adhesive transdermal drug delivery system
AU2002353444A1 (en) Integrated transdermal drug delivery system
AU1585601A (en) Transdermal administration of huperzine
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2003221770A1 (en) Controlled release transdermal drug delivery
AU2003276656A1 (en) Transdermal delivery system for anti-emetic medication
AU2938100A (en) Transdermal drug delivery system and method
AU4947100A (en) Drug delivery device
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU4496900A (en) Improved drug delivery pack
AU6017698A (en) Fillable patch for dermal or transdermal delivery
AU2001275286A1 (en) Transdermal delivery
AU2001292781A1 (en) Acryl adhesive useful in transdermal drug delivery systems
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
GB0119012D0 (en) Transdermal delivery of drugs
AU2001270963A1 (en) Transdermal drug delivery system
AU2003212962A1 (en) Transdermal drug delivery systems
AU5460800A (en) Pharmaceutical transdermal compositions
AU2003241134A1 (en) Transdermal drug delivery system
AU4916501A (en) Packaging materials for transdermal drug delivery systems
HUP0202592A3 (en) Transdermal delivery of lasofoxifene
AU6457700A (en) Transdermal patch comprising methylphenidate
AU6751000A (en) Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery
AU6503399A (en) Drug delivery catheter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase